Thinking about buying stock in Check Cap, ContextLogic, Marin Software, Atossa Therapeutics, or Altimmune?

NEW YORK, June 30, 2021

To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.

• CHEK: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=CHEK&prnumber=063020216
• WISH: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=WISH&prnumber=063020216
• MRIN: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=MRIN&prnumber=063020216
• ATOS: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ATOS&prnumber=063020216
• ALT: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?stocksymbol=ALT&prnumber=063020216

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-check-cap-contextlogic-marin-software-atossa-therapeutics-or-altimmune-301323287.html